💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueLearn More

West Pharmaceutical Services Inc (WST)

NYSE
Currency in USD
Disclaimer
299.38
-2.65(-0.88%)
Real-time Data
WST Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
299.02304.10
52 wk Range
265.00413.70
Prev. Close
302.03
Open
301.97
Day's Range
299.02-304.1
52 wk Range
265-413.7
Volume
123,084
Average Vol. (3m)
609,867
1-Year Change
-23.18%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
WST Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
351.85
Upside
+17.37%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 31 consecutive years
Show more

West Pharmaceutical Services Inc Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Compare WST to Peers and Sector

Metrics to compare
WST
Peers
Sector
Relationship
P/E Ratio
41.7x13.8x−0.6x
PEG Ratio
16.81−1.170.00
Price / Book
8.5x2.0x2.6x
Price / LTM Sales
7.6x1.9x3.1x
Upside (Analyst Target)
14.2%117.0%56.2%
Fair Value Upside
Unlock31.2%7.7%Unlock

People Also Watch

806.50
CTAS
+0.22%
290.96
CB
-0.42%
898.17
LLY
-1.11%
369.29
SHW
+1.48%

FAQ

What Is the West Pharmaceutical Services (WST) Stock Price Today?

The West Pharmaceutical Services stock price today is 299.38

What Stock Exchange Does West Pharmaceutical Services Trade On?

West Pharmaceutical Services is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for West Pharmaceutical Services?

The stock symbol for West Pharmaceutical Services is "WST."

Does West Pharmaceutical Services Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.26%.

What Is the West Pharmaceutical Services Market Cap?

As of today, West Pharmaceutical Services market cap is 21.75B.

What is West Pharmaceutical Services Earnings Per Share?

The West Pharmaceutical Services EPS is 7.12.

What Is the Next West Pharmaceutical Services Earnings Date?

West Pharmaceutical Services will release its next earnings report on Oct 24, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.